Objective Acute myeloid leukemia (AML) is a clonal disorder of hematopoietic precursor cells characterized by uncontrolled proliferation of neoplastic cells and impaired inhibition of normal hematopoiesis.Although remarkable progress has been made in the treatment of this deadly disease over the past few decades,the outcome remains poor.